Siren Biotechnology and RISE Robotics Triumph at Superpowers for Good Live Pitch Q2 2025
The second quarter edition of the Superpowers for Good Live Pitch concluded with Siren Biotechnology and RISE Robotics being recognized for their groundbreaking work. Dr....
Rocky Romanella Shares Insights on Balanced Leadership and Success
Rocky Romanella, a renowned keynote speaker and author, emphasizes the significance of Balanced Leadership in achieving excellence in both business and personal life. His approach...
1929 Ford Model A Speedster Boattail Enhances Ron Sturgeon Collection
The Ron Sturgeon Collection has recently welcomed a remarkable piece of automotive history, a 1929 Ford Model A Speedster Boattail, showcasing the blend of artful...
Salon Suite Rental Offers Independence and Control for Beauty Professionals
For beauty and wellness professionals, the decision between leasing a salon suite and traditional salon employment is pivotal, affecting their career trajectory, financial stability, and...
LaFleur Minerals Inc. Advances Toward Gold Production in Québec’s Abitibi Gold Belt
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) has been featured in a recent Audio Press Release by NetworkNewsAudio, highlighting its progress toward near-term...
TCU Basketball Teams Join Nation of Lifesavers in CPR Training Initiative
The Texas Christian University (TCU) men’s and women’s basketball teams have taken a significant step towards becoming part of the Nation of Lifesavers by participating...
Beeline Holdings, Inc. Completes Landmark Crypto-Backed Real Estate Transaction
Beeline Holdings, Inc. (NASDAQ: BLNE) has announced a significant milestone in the financial technology sector with its subsidiary, Beeline Title Holdings, Inc., successfully completing a...
G Mining Ventures Corp. Secures Shareholder Approval for All AGM Resolutions
G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) has reported that all resolutions proposed in its May 27, 2025 Notice of Meeting and Information Circular...
Calidi Biotherapeutics Inc. Advances Oncolytic Immunotherapy Pipeline with Strategic Focus in 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotech company, has made notable strides in its development of systemic oncolytic targeted immunotherapies, as detailed in...